Real-World Evaluation of the Impact of the Anti-fibrotics in Patients with Idiopathic Pulmonary Fibrosis and Other Fibrotic Lung Diseases

被引：0

作者：

Dempsey, T. M. ^{[1
]}

Thao, V. ^{[2
]}

Sangaralingham, L. ^{[2
]}

Limper, A. H. ^{[3
]}

机构：

[1] David Grant Med Ctr, Pulm & Crit Care, Travis AFB, CA USA

[2] Mayo Clin, Kern Ctr Study Hlth Care Delivery, Rochester, MN USA

[3] Mayo Clin, Div Pulm & Crit Care, Rochester, MN USA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A2429

引用

页数：1

共 50 条

[41] Anti-fibrotic effects of pirfenidone in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
Hostettler, Katrin
Papakonstantinou, Eleni
Klagas, Ioannis
Bonovolias, Ioannis
Sun, Qingzhu
Tamm, Michael
Lambers, Christopher
Roth, Michael
EUROPEAN RESPIRATORY JOURNAL, 2015, 46
[42] Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
Katrin E Hostettler
Jun Zhong
Eleni Papakonstantinou
George Karakiulakis
Michael Tamm
Petra Seidel
Qingzhu Sun
Jyotshna Mandal
Didier Lardinois
Christopher Lambers
Michael Roth
Respiratory Research, 15
[43] REAL-WORLD TOLERABILITY STUDY OF NINTEDANIB IN PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE COMPARED TO PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
Newman, K.
Gadoot, T.
Stranks, L.
Morris, H.
Zakis, K.
Swale, J.
Greaves, M.
Stanel, S.
Ramjug, S.
Avram, C.
Blaikley, J.
Leonard, C.
Hayton, C.
Rivera-Ortega, P.
THORAX, 2022, 77 : A96 - A96
[44] Real-World Study Analysing Progression and Survival of Patients with Idiopathic Pulmonary Fibrosis with Preserved Lung Function on Antifibrotic Treatment
Saba Noor
Saira Nawaz
Nazia Chaudhuri
Advances in Therapy, 2021, 38 : 268 - 277
[45] Real-World Study Analysing Progression and Survival of Patients with Idiopathic Pulmonary Fibrosis with Preserved Lung Function on Antifibrotic Treatment
Noor, Saba
Nawaz, Saira
Chaudhuri, Nazia
ADVANCES IN THERAPY, 2021, 38 (01) : 268 - 277
[46] Real-life survival of idiopathic pulmonary fibrosis with anti-fibrotic medication
Bleinc, Alexandre
Blin, Timothee
Legue, Sylvie
Mankikian, Julie
Plantier, Laurent
Marchand-Adam, Sylvain
REVUE DES MALADIES RESPIRATOIRES, 2023, 40 (05) : 371 - 381
[47] Real-World Application of a Molecular Classifier in the Diagnosis of Idiopathic Pulmonary Fibrosis
George, G.
Hehn, B. T.
Summer, R. S.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
[48] Longitudinal "Real-World" Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
Tzouvelekis, Argyrios
Karampitsakos, Theodoros
Ntolios, Paschalis
Tzilas, Vasilios
Bouros, Evangelos
Markozannes, Evangelos
Malliou, Ioanna
Anagnostopoulos, Aris
Granitsas, Andreas
Steiropoulos, Paschalis
Dimakou, Katerina
Chrysikos, Serafeim
Koulouris, Nikolaos
Bouros, Demosthenes
FRONTIERS IN MEDICINE, 2017, 4 : 1 - 1
[49] Outcome of lung transplantation in idiopathic pulmonary fibrosis with previous anti-fibrotic therapy
Leuschner, Gabriela
Stocker, Florian
Veit, Tobias
Kneidinger, Nikolaus
Winter, Hauke
Schramm, Rene
Weig, Thomas
Matthes, Sandhya
Ceelen, Felix
Arnold, Paola
Munker, Dieter
Klenner, Friederike
Hatz, Rudolf
Frankenberger, Marion
Behr, Juergen
Neurohr, Claus
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (02): : 268 - 274
[50] REAL-WORLD MULTICENTER PROSPECTIVE STUDY OF COMBINATION THERAPY OF ANTI-FIBROTIC AGENTS IN IDIOPATHIC PULMONARY FIBROSIS (J-AVENGERS): INTERIM ANALYSIS
Inomata, Minoru
Kuse, Naoyuki
Awano, Nobuyasu
Sakamoto, Keita
Fujimoto, Kazushi
Muto, Yutaka
Ito, Yu
Chin, Haruka
Umezawa, Hiroki
Tanaka, Kensuke
Nakamura, Yasuhiko
Isshiki, Takuma
Kishi, Kazuma
Izumo, Takehiro
CHEST, 2023, 164 (04) : 3039A - 3040A

← 1 2 3 4 5 →